Controlled clinical evaluation of depot neuroleptics. A double-blind trial with pipotiazine undecylenate and fluphenazine enanthate.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005476:Fluphenazine / Q000627:therapeutic use*; D006801:Humans; D010880:Piperidines / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D014476:Undecylenic Acids / Q000627:therapeutic use
D014150:Antipsychotic Agents; D010880:Piperidines; D010919:Placebos; D013449:Sulfonamides; D014476:Undecylenic Acids; D005476:Fluphenazine